SCHEMBL5673003

SCHEMBL5673003

S=C1Nc2ccccc2OC1c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
ALOX5 P09917 1/20 0.41
CA2 P00918 1/20 0.41
NR3C1 P04150 5/20 0.39
AR P10275 4/20 0.39
PGR P06401 3/20 0.39
NR3C2 P08235 2/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
BRD4 O60885 2/20 0.39
CREBBP Q92793 2/20 0.39
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
EGFR P00533 2/20 0.36
ADK P55263 1/20 0.36
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5670399 0.79 CA2 (0.62) PARP1ALOX5CA2NR3C1AR
SCHEMBL31563602 0.71 BRD4 (0.37) PARP1ALOX5CA2NR3C1AR
SCHEMBL7985016 0.71 PGR (0.45) PARP1ALOX5CA2NR3C1PGR
SCHEMBL7982133 0.70 PARP1 (0.45) PARP1ALOX5NR3C1BRD4CREBBP
SCHEMBL5670843 0.70 PARP1 (0.45) PARP1ALOX5NR3C1BRD4CREBBP
SCHEMBL7984452 0.70 PARP1 (0.45) PARP1ALOX5BRD4CREBBPKMT2A
SCHEMBL5672871 0.70 ALDH1A1 (0.41) PARP1ALOX5PGRBRD4CREBBP
SCHEMBL7982283 0.69 EGFR (0.54) KMT2AMEN1MAPTEGFRALDH1A1
SCHEMBL13602802 0.68 KMT2A (0.59) PARP1CA2NR3C1ARPGR
SCHEMBL7988315 0.68 PARP1 (0.42) PARP1ALOX5NR3C1ARPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0980362-B1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AG (DE) 2006-08-16 EP disclosed
US-6191127-B1 ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0980362-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2000-02-23 EP disclosed
WO-1998050372-A1 SUBSTITUTED HETEROCYCLES AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-11-12 WO disclosed